Chronic kidney disease (CKD) is frequently observed in patients with arterial hypertension.
The same factors that promote the appearance and progression of atherosclerosis can also …

Treatment of cholesterol in people with advanced stage chronic kidney disease (CKD)
clearly reduces cardiovascular risk; however, it does not significantly slow nephropathy …

Introduction: Statin has been reported to reduce cardiovascular events. However, the
comparative efficacy of statin with standard therapy on cardiovascular events has not been …

People with end‐stage kidney disease (ESKD) who require chronic dialysis are often reliant
on complicated medication regimens to manage their health conditions. Due to the …

The prevalence of chronic kidney disease (CKD) is rising in the United States, and
cardiovascular disease (CVD) is increasingly recognized to occur at elevated rates in …

Background: Patients with end-stage renal disease on hemodialysis have excess
cardiovascular disease (CVD) burden with substantially increased CV event rates compared …

Introduction: One of the major complications in hemodialysis patients is cardiovascular
disease. Lipid abnormality is an important factor in the development of cardiovascular …

目的: 探讨慢性肾功能衰竭维持性血液透析患者动静脉内瘘血流量对其心功能的影响.
方法选取70 例应用动静脉内瘘行血液透析患者为研究对象, 术后1 个月开始使用内瘘时根据 …

Background Cardiovascular events are the leading cause of death in end stage renal
disease (ESRD), but traditional markers of dyslipidemia are not clearly associated with …

Показана роль эндотелия в регуляции сосудистого тонуса, гемостаза, иммунного
ответа, в синтезе факторов воспаления и их ингибиторов. Оценено влияние …